The use of musculo-skeletal system medicine in Sweden shows fluctuating but generally increasing trends from 2013 to 2023. The value in 2023 stood at 73.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day, with notable year-on-year variations such as a significant drop in 2020 by -5.26% and a rise in 2022 by 4.68%. The average compound annual growth rate (CAGR) over the last five years was 0.98%, indicating modest growth.
Looking forward, the forecast data suggests a stabilization in the usage levels with minimal growth, as indicated by a forecasted average CAGR of 0.03% over the next five years. This trend implies that the usage of musculo-skeletal system medicine is likely to remain relatively stable through 2028.
Future trends to watch for include potential impacts from demographic changes, such as an aging population which may lead to increased demand, and advancements in medical treatments which could either reduce or increase the need for musculo-skeletal system medicines. Monitoring these factors will be crucial for accurate future forecasting.
